BioSpace News Archive

Teva Issues Recall of Tainted Blood Pressure Medicine, the Latest Global Recall for Valsartan

There has been another recall for blood pressure medications. This time Teva Pharmaceutical has issued a voluntary recall for combination forms of its blood pressure drug Amlodipine due to cancer-causing impurities discovered in the tablets.

November 28, 2018
·
2 min read
·
Alex Keown
Business

Anti-Vaccine Movement Causes First Deaths, Doctor Says

More than 200 children have died this year from influenza and 80 percent were not vaccinated, expert says.

November 28, 2018
·
2 min read
·
Alex Keown
Business

CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments

CBT’s c-Met inhibitor and anti-PD1 antibody to be evaluated in combination with Bossan’s EGFR inhibitor

November 28, 2018
·
4 min read
Business

Fusion Antibodies plc Interim Report for the six months ended 30 September 2018

Fusion Antibodies plc announces its unaudited interim results for the six months ended 30 September 2018.

November 28, 2018
·
1 min read
Business

Second Pregnancy Reported by Chinese CRISPR Researcher as Ethical and Legal Investigations Launch

Chinese researcher He Jiankui earlier reported that a set of twins had been born who underwent CRISPR gene editing as fetuses. He followed up last night, stating that another one of the seven couples he experimented on is pregnant.

November 28, 2018
·
4 min read
·
Mark Terry
Business

BC Platforms and University of Nottingham to create a Health Data Discovery Platform for the UK’s National Biobank Network

It is anticipated that this initial concept will be scaled to all UK biobanks and genomic cohorts and will be replicated across European countries wanting to adopt the UK model through working with European organisations such as BBMRI-ERIC and ELIXIR.

November 28, 2018
·
4 min read
Business

Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2015

Every year, BioSpace analyzes the biotech industry, looking for the hot new biotech startups to watch. Here’s a look at the top 3 companies from the Top 30 Life Science Startups to Watch in the U.S. from 2015.

November 28, 2018
·
4 min read
·
Mark Terry
Drug Development

MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study (NOVA) to Evaluate Guselkumab in Hidradenitis Suppurativa

MorphoSys AG announced today that its licensee Janssen Research & Development, LLC (Janssen) initiated a phase 2 clinical study of guselkumab in patients with moderate to severe hidradenitis suppurativa (HS), a chronic skin disease also known as acne inversa.

November 28, 2018
·
6 min read
Drug Development

ACACIA PHARMA ANNOUNCES POSITIVE BARHEMSYS™ RESCUE TREATMENT DATA PUBLISHED IN ANESTHESIOLOGY

Acacia Pharma Group plc announces that data and analyses from its positive Phase 3 clinical trial of BARHEMSYS™ have been published (Habib et al1) in the online edition of the leading peer-reviewed journal Anesthesiology, the official publication of the American Society of Anesthesiologists.

November 28, 2018
·
5 min read
Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as one of the commonly used maintenance medications in COPD (Chronic Obstructive Pulmonary Disease).

November 28, 2018
·
2 min read